An affected pedigree member analysis of linkage between the dopamine D2 receptor gene TaqI polymorphism and obesity and hypertension

被引:35
|
作者
Fang, YJ
Thomas, GN
Xu, ZL
Fang, JQ
Critchley, AJH
Tomlinson, B
机构
[1] Univ Hong Kong, Dept Community Med, Hong Kong, Hong Kong, Peoples R China
[2] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Med & Therapeut, Shatin, Hong Kong, Peoples R China
[3] Sun Yat Sen Univ Med Sci, Dept Med Stat, Guangzhou, Peoples R China
关键词
affected pedigree member sib-pair analysis; metabolic syndrome; central obesity; dopamine D2 receptor gene; hypertension;
D O I
10.1016/j.ijcard.2004.05.010
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Dopamine modulates a variety of physiological functions including natriuresis and satiety. We have previously reported that the TaqI polymorphism of the dopamine D2 receptor (DD2R) gene is associated with both blood pressure and obesity indices in a normoglycaemic Hong Kong Chinese population. In this study, we present evidence confirming the linkage between this gene polymorphism, obesity and hypertension. Methods: Two hundred and seventy-four siblings from 96 normoglycaemic hypertensive families were recruited, including 133 who were hypertensive. Central obesity was defined as a waist-to-hip ratio of >= 0.9 and >= 0.85 in males and females, respectively, and was identified in 99 of the siblings. The DD2R gene TaqI polymorphism was identified with a polymerase chain reaction based restriction fragment length polymorphism protocol. The affected pedigree member (APM) linkage analysis (sib-pair program, version 0.99.9, by D.L. Duffy) was used to assess for linkage between this gene polymorphism, obesity and hypertension in 73 families with siblings discordant for hypertension. Results: The At allele frequencies were similar in the 133 hypertensive, and 141 normotensive siblings, including the 99 centrally obese siblings at 0.431. 0.421 and 0.418, respectively. APM linkage analysis suggested that the DD2R gene TaqI polymorphism had evidence of linkage with blood pressure (T=-1.86, P=0.013), as well as with obesity (T=-1.58, P=0.007). Conclusion: Our data in normoglycaemic Hong Kong Chinese supports that the DD2R gene TaqI polymorphism is a marker associated with the pathogenesis of obesity and hypertension. (c) 2004 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:111 / 116
页数:6
相关论文
共 50 条
  • [1] An affected pedigree member analysis of the linkage between the Taql polymorphism of the dopamine D2 receptor gene and obesity-related hypertension in Hong Kong Chinese
    Fang, YJ
    Thomas, GN
    Xu, ZL
    Fang, JQ
    Tomlinson, B
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 41 (06) : 311A - 311A
  • [2] Modulation of blood pressure and obesity with the dopamine D2 receptor gene TaqI polymorphism
    Thomas, GN
    Tomlinson, B
    Critchley, JAJH
    HYPERTENSION, 2000, 36 (02) : 177 - 182
  • [3] Dopamine D2 receptor TaqI a polymorphism and Parkinson's disease
    Zappia, M
    Annesi, G
    Quattrone, A
    MOVEMENT DISORDERS, 2001, 16 (05) : 975 - 975
  • [4] Male limited association of the dopamine receptor D2 gene TaqI A polymorphism and alcohol dependence
    Limosin, F
    Gorwood, P
    Loze, JY
    Dubertret, C
    Gouya, L
    Deybach, JC
    Adès, J
    AMERICAN JOURNAL OF MEDICAL GENETICS, 2002, 112 (04): : 343 - 346
  • [5] Association study of NcoI and TaqI A dopamine receptor D2 gene polymorphism in opium addicts
    Gareeva, AE
    Yuriev, EB
    Khusnutdinova, EK
    ZHURNAL NEVROPATOLOGII I PSIKHIATRII IMENI S S KORSAKOVA, 2004, 104 (04): : 46 - 49
  • [6] Association of the TaqI a polymorphism of the dopamine D2 receptor gene with predisposition to neuroleptic malignant syndrome
    Suzuki, A
    Kondo, T
    Otani, K
    Mihara, K
    Yasui-Furukori, N
    Sano, A
    Koshiro, K
    Kaneko, S
    AMERICAN JOURNAL OF PSYCHIATRY, 2001, 158 (10): : 1714 - 1716
  • [7] NO LINKAGE BETWEEN D2 DOPAMINE RECEPTOR GENE REGION AND SCHIZOPHRENIA
    MOISES, HW
    GELERNTER, J
    GIUFFRA, LA
    ZARCONE, V
    WETTERBERG, L
    CIVELLI, O
    KIDD, KK
    CAVALLISFORZA, LL
    GRANDY, DK
    KENNEDY, JL
    VINOGRADOV, S
    MAUER, J
    LITT, M
    SJOGREN, B
    ARCHIVES OF GENERAL PSYCHIATRY, 1991, 48 (07) : 643 - 647
  • [8] Lack of effect of D2 dopamine receptor TaqI A polymorphism on smoking cessation
    Berlin, I
    Covey, LS
    Jiang, HP
    Hamer, D
    NICOTINE & TOBACCO RESEARCH, 2005, 7 (05) : 725 - 728
  • [9] Association of TaqI polymorphism of the dopamine D2 receptor gene in schizophrenic and schizoaffective patients of a Russian population
    Aksenova, M
    Golimbet, VE
    Abramova, LI
    Kaleda, VG
    Orlova, VA
    Brusentseva, LN
    Kaidan, TS
    Pekarskaya, LI
    Serebrennikova, IE
    Kesselman, LG
    Lyaschenko, GL
    Braga, EA
    Nosikov, VV
    EUROPEAN JOURNAL OF HUMAN GENETICS, 1998, 6 : 128 - 128
  • [10] Association between TaqI A dopamine D2 receptor polymorphism and therapeutic response to bromperidol:: a preliminary report
    Suzuki, A
    Kondo, T
    Mihara, K
    Yasui-Furukori, N
    Otani, K
    Furukori, H
    Kaneko, S
    Inoue, Y
    EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE, 2001, 251 (02) : 57 - 59